Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

One2 Treat Appoints Dr. Pascal Piedbois As Key Driver In Incorporating Patient Relevant Outcomes

PRIVATEJul 09, 2024•almost 2 years ago

Position

Chief Executive Officer

Company

One2Treat

Sebastien Coppe

Louvain-la-NeuveBiotechnologyHealth Careresearch

Description

One2Treat appoints Dr. Pascal Piedbois, Prof. of Medical Oncology, with over 30 years of clinical development experience, to ensure the development and delivery of the One2Treat suite of offerings with the requirements of patients and clinical teams at the forefront

Company Information

Company

One2Treat

Location

Louvain-la-Neuve, Wallonie, Belgium

About

One2Treat is a forward-thinking partner for biopharmaceutical companies, dedicated to delivering transformative insights in clinical trial design, analysis, and market access evaluations to support holistic treatment decisions. One2Treat was founded in July 2023 after four years of advanced Research and Software Development incubation within IDDI Group.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for One2Treat's next move

Learn about Strategic plan

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months